Literature DB >> 22885170

Control of low-threshold exocytosis by T-type calcium channels.

Norbert Weiss1, Gerald W Zamponi.   

Abstract

Low-voltage-activated (LVA) T-type Ca²⁺ channels differ from their high-voltage-activated (HVA) homologues by unique biophysical properties. Hence, whereas HVA channels convert action potentials into intracellular Ca²⁺ elevations, T-type channels control Ca²⁺ entry during small depolarizations around the resting membrane potential. They play an important role in electrical activities by generating low-threshold burst discharges that occur during various physiological and pathological forms of neuronal rhythmogenesis. In addition, they mediate a previously unrecognized function in the control of synaptic transmission where they directly trigger the release of neurotransmitters at rest. In this review, we summarize our present knowledge of the role of T-type Ca²⁺ channels in vesicular exocytosis, and emphasize the critical importance of localizing the exocytosis machinery close to the Ca²⁺ source for reliable synaptic transmission. This article is part of a Special Issue entitled: Calcium channels.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22885170     DOI: 10.1016/j.bbamem.2012.07.031

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  T-type Ca(2+) channels make your brain smarter.

Authors:  Norbert Weiss
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

2.  Surfen is a broad-spectrum calcium channel inhibitor with analgesic properties in mouse models of acute and chronic inflammatory pain.

Authors:  Paula Rivas-Ramirez; Vinicius M Gadotti; Gerald W Zamponi; Norbert Weiss
Journal:  Pflugers Arch       Date:  2017-06-30       Impact factor: 3.657

Review 3.  T-type channel-mediated neurotransmitter release.

Authors:  Emilio Carbone; Chiara Calorio; David H F Vandael
Journal:  Pflugers Arch       Date:  2014-03-06       Impact factor: 3.657

4.  Cooperative roles of glucose and asparagine-linked glycosylation in T-type calcium channel expression.

Authors:  Joanna Lazniewska; Yuriy Rzhepetskyy; Fang-Xiong Zhang; Gerald W Zamponi; Norbert Weiss
Journal:  Pflugers Arch       Date:  2016-09-23       Impact factor: 3.657

Review 5.  T-type calcium channels in synaptic plasticity.

Authors:  Nathalie Leresche; Régis C Lambert
Journal:  Channels (Austin)       Date:  2016-09-21       Impact factor: 2.581

6.  Modulation of Cav3.2 T-type calcium channel permeability by asparagine-linked glycosylation.

Authors:  Katarina Ondacova; Maria Karmazinova; Joanna Lazniewska; Norbert Weiss; Lubica Lacinova
Journal:  Channels (Austin)       Date:  2016-01-08       Impact factor: 2.581

7.  Surface expression and function of Cav3.2 T-type calcium channels are controlled by asparagine-linked glycosylation.

Authors:  Norbert Weiss; Stefanie A G Black; Chris Bladen; Lina Chen; Gerald W Zamponi
Journal:  Pflugers Arch       Date:  2013-03-16       Impact factor: 3.657

Review 8.  T-type calcium channels in chronic pain: mouse models and specific blockers.

Authors:  Amaury François; Sophie Laffray; Anne Pizzoccaro; Alain Eschalier; Emmanuel Bourinet
Journal:  Pflugers Arch       Date:  2014-03-04       Impact factor: 3.657

9.  Intra-membrane signaling between the voltage-gated Ca2+-channel and cysteine residues of syntaxin 1A coordinates synchronous release.

Authors:  Niv Bachnoff; Moshe Cohen-Kutner; Michael Trus; Daphne Atlas
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies.

Authors:  Song Cai; Peter Tuohy; Chunlong Ma; Naoya Kitamura; Kimberly Gomez; Yuan Zhou; Dongzhi Ran; Shreya Sai Bellampalli; Jie Yu; Shizhen Luo; Angie Dorame; Nancy Yen Ngan Pham; Gabriella Molnar; John M Streicher; Marcel Patek; Samantha Perez-Miller; Aubin Moutal; Jun Wang; Rajesh Khanna
Journal:  Pain       Date:  2020-11       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.